Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy Against Kidney Fibrosis

1Icahn School of Medicine at Mount Sinai, NY, NY 10029

2Rila Therapeutics Inc., South San Francisco, CA 94080

3ShangPharma Innovations Inc., South San Francisco, CA 94080

aCorresponding authors: John Cijiang He, M.D./Ph.D. or Kyung Lee, Ph.D. Division of Nephrology, Box 1243 Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place New York NY 10029 Tel: 212-659-1703, Fax: 212-987-0389 Email: [email protected] or [email protected]

Comments (0)

No login
gif